Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-22

Clinical Trial Update: Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is studying the effects of psilocybin on speech fluency, struggle, and brain activity in people who stutter; the study is not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: NYU Langone Health | Conditions: Stuttering | Phase 2 | Status: NOT_YET_RECRUITING